Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling

Src family tyrosine kinase (SFK) activation is associated with ovarian cancer progression. Therefore, SFKs are targets for the development of potential treatments of ovarian cancer. Dasatinib is a tyrosine kinase inhibitor that targets SFK activity, and is used for the treatment of B cell and Abelso...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Med Rep
Main Authors: XIAO, JUAN, XU, MANMAN, HOU, TENG, HUANG, YONGWEN, YANG, CHENLU, LI, JUNDONG
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2015
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526065/
https://ncbi.nlm.nih.gov/pubmed/25975261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.3784
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker